Pulmonary Function Technology (PFT) Recredentialing Package

As our understanding of COPD continues to grow, so do our diagnostic and assessment options. This presentation will go beyond spirometry to look at additional tools RTs can use to evaluate treatable traits in COPD and provide more individualized care for everyone living with obstructed airflow.

Approved for 1.0 CRCE

Speaker Information

Presenter:

• Mike Hess, MPH, RRT, RPFT

Moderator:

• Lanny Inabnit, MS, RRT, RRT-ACCS, RRT-NPS, FAARC

This presentation will identify the role of exercise testing in the evaluation of upper airway symptoms and the diagnostic tools available to evaluate the patient condition. This will include a discussion about flow-volume loop analysis and direct video-laryngoscopy performed during exercise.

Approved for 1.0 CRCE

Speaker Information

• Katrina Hynes MHA, RRT, RPFT

Cardiopulmonary Exercise Testing (CPET) is a valuable tool for evaluating exercise capacity and predicting outcome in patients with various conditions. This presentation will discuss various devices and protocols used for CPET as well as the normal ventilatory responses to exercise.

Approved for 1.0 CRCE

Speaker Information

• Carl Mottram, RRT, RPFT, FAARC

The noninvasive measurement of exhaled nitric oxide (FeNO) may be useful in the diagnosis and treatment of respiratory diseases. This presentation will discuss the mechanism of FeNO production, how to interpret the test results, and how this measurement can be used in both pulmonary medicine and primary care.

Approved for 1.0 CRCE

Speaker Information

• Kaiser Lim, MD

In this session focused on bronchoprovocation tests, the presenter will focus on indirect bronchoprovocation. Indirect bronchoprovocation testing is focused on producing reactions in the airway smooth muscle cells by stimulating airway inflammatory cells and demonstrates high specificity and relatively low sensitivity. This presentation will differentiate indirect bronchoprovocation from direct and explore the effectiveness of various types of indirect testing.

Approved for 1.0 CRCE

Speaker Information

• Karina Keogh, MD

This spirometry course will discuss obstructive and restrictive disease processes, basic measurements, reference values, repeatability and acceptability, and how to perform a quality procedure. Also discussed is calibration of the spirometer and patterns of abnormal results.

Approved for 2.0 CRCE

Speaker Information

• Curt Merriman, BA, RRT, CPFT

In this presentation the speaker will discuss the Editor’s Choice of the August 2022 issue of RESPIRATORY CARE “Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing”. The presentation will focus on the research design and interpretation of the results.

Approved for 1.0 CRCE

Speaker Information

Presenter:

• Jeffrey Haynes RRT, RPFT, FAARC

Moderator

• Carl Mottram RRT, RPFT, FAARC

This presentation will review the newer ATS-ERS technical standards and their impact on the PFT practitioner, discuss the key elements of quality control described in these technical standards, and explain the importance of following the testing schemes laid out in the standards.

Approved for 1.0 CRCE

Speaker Information

Presenter:

• Carl Mottram RRT, RPFT, FAARC

Moderator:

• Kenny Harker BSRT, RRT, RPFT

Respiratory therapists are vital to the accurate diagnosis of various pulmonary diseases and are the cornerstone of good pulmonary diagnostic tests. One of these tests, used to diagnose the reactivity of the airway, is the methacholine challenge test. While this test has been conducted for many years, recent guidelines and the availability of medication have complicated the clinician’s ability to recommend and conduct the challenge test. This presentation will explore the indications, methods, and technical aspects of the methacholine challenge test.

Approved for 1.0 CRCE

Speaker Information

• Kaiser Lim, MD
• Carl D Mottram, RRT, RPFT, FAARC